VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.72 Cr | ₹-4.24 Cr | ₹-1.99 Cr | ₹-0.90 Cr | ₹-0.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VIMTA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹-7.72 Cr |
| Mar2023 | ₹-4.24 Cr |
| Mar2022 | ₹-1.99 Cr |
| Mar2021 | ₹-0.90 Cr |
| Mar2020 | ₹-0.44 Cr |
How is Deferred Tax Assets / Liabilities of VIMTA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-7.72 Cr | Negative | |
| Mar2023 | ₹-4.24 Cr | Negative | |
| Mar2022 | ₹-1.99 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | Negative | |
| Mar2020 | ₹-0.44 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,938.3 Cr | -13.4% | -27.3% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -13.4% |
-27.3% |
-1.3% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses